These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4762740)

  • 1. [Chemotherapeutic properties of sanquiritrin in treatment of experimental candidiasis].
    Vichkanova SA; Adgina VV
    Antibiotiki; 1973 Oct; 18(10):902-5. PubMed ID: 4762740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of trichomycin in the treatment of experimental mycoses].
    Medvedkova AA; Liubimova LK; Frolova MA; Paĭkin MD; Slonitskaia NN
    Antibiotiki; 1966 Jun; 11(6):536-40. PubMed ID: 6011784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathomorphology of experimental candidiasis in mice treated with sodium salt of an N-succinyl derivative of perimycin].
    Hrabowska M
    Acta Biol Med (Gdansk); 1969; 14(3):227-53. PubMed ID: 5396660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapeutic effect of the cholesterin-levorin complex].
    Klimov AN; Nikiforova AA
    Antibiotiki; 1971 Feb; 16(2):120-2. PubMed ID: 5557385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental cockscomb candidiasis as a model for testing antifungal agents effective against blastomyces].
    Kramer A; Rödel R; Krause R; Weuffen W; Kühne R
    Z Gesamte Hyg; 1974; 20(8):509-12. PubMed ID: 4462317
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antifungal properties and chemotherapeutic activity of the iso-butyl ester of propane thiosulfonic acid].
    Skorobogat'ko TI
    Mikrobiol Zh; 1969; 31(6):674-8. PubMed ID: 5408536
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
    Hope WW; Drusano GL; Moore CB; Sharp A; Louie A; Walsh TJ; Denning DW; Warn PA
    Antimicrob Agents Chemother; 2007 Jan; 51(1):285-95. PubMed ID: 17088486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of drugs currently used in treatment on indices of the body's immune reactivity in experimental candidiasis and aspergillosis].
    Leshchenko VM; Il'chenko LS; Leshchenko GM
    Vestn Dermatol Venerol; 1983 Aug; (8):19-23. PubMed ID: 6637064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Model of experimental Candida mycosis for testing fungistatics].
    Kulikova VN; Minasian MA; Razbitskaia GT
    Veterinariia; 1979 Jan; (1):47-8. PubMed ID: 419668
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effectiveness of the sodium salt of N-succinylperimycin and nystatin in experimental candidiasis of white mice.
    Rutecka-Bonin I
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):547-53. PubMed ID: 4952937
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antifungal properties of sanquinarin].
    Vichkanova SA; Adgina VV
    Antibiotiki; 1971 Jul; 16(7):609-12. PubMed ID: 5168224
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effectiveness of the sodium salt of N-succinylperimycin and nystatin in experimental candidiasis of white mice.
    Rutecka-Bonin I
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):547-53. PubMed ID: 5106790
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal activity of fenticonazole in experimental dermatomycosis and candidiasis.
    Veronese M; Barzaghi D; Bertoncini A
    Arzneimittelforschung; 1981; 31(12):2137-9. PubMed ID: 7199314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features of the course of the candida infection process during combined effect of medications].
    Khmel'nitskĭi OK; Kotovich VM
    Biull Eksp Biol Med; 1995 Nov; 120(11):506-10. PubMed ID: 8713330
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of fluconazole treatment on tumor necrosis factor-alpha production in murine candidiasis.
    Kalkanci A; Kustimur S
    Yale J Biol Med; 2002; 75(5-6):241-5. PubMed ID: 14580106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with visceral candidiasis].
    Makova GN; Kurbatova IV
    Ter Arkh; 2003; 75(8):76-8. PubMed ID: 14520858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds.
    Khan MA; Ashfaq MK; Zuberi HS; Mahmood MS; Gilani AH
    Phytother Res; 2003 Feb; 17(2):183-6. PubMed ID: 12601685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.
    Hope WW; Drusano GL
    Clin Microbiol Infect; 2009 Jul; 15(7):602-12. PubMed ID: 19673971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First trials with the cockscomb candidiasis test as an in vitro screening model for antifungal agents].
    Kramer A; Krause R; Weuffen W; Rödel B
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):259-62. PubMed ID: 1236886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticandida properties of certain derivatives of beta-nitrostyrene].
    Bilich BE; Cherkasov VM; Vladimirtsev IF
    Vestn Dermatol Venerol; 1970 Jan; 44(1):55-8. PubMed ID: 5426800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.